NAS10027,088+1.72%S&P7,415+0.84%GOLD$4,061−1.27%BTC$75,685−0.34%VIX24.44−13.27%latest tape · as of 16:01 UTC
The Screen · Industrials · Aerospace & Defense
Planet Labs PBC
PL · the NYSE · USD · Market cap $4.9B · 945 employees
Planet Labs PBC engages in the design, construction, and launch of constellations of satellites with the intent of providing high-cadence geospatial data delivered to customers through an online platform in the United St…
FAIL · Does not pass the screen
11.37 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 16:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price11.37 USD at the 5 Nov 2026 close
Fair valueUnder review: our model's value is 2.21x the price, above our 2.00x limit.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.51, read 2026-11-02
Ethical does not pass the values gate
Price11.37 USD
Fair valueUnder review
Ethical score30.0/100
Our investment reviews on this name
2026-10-18Read Markdown13.56-16.2% to today ✓Accumulation gives way to Markdown after a 17% slide in 7 days
2026-10-11Read Accumulation16.38-30.6% to today Markdown gives way to Accumulation after a 24% slide in 6 weeks
2026-09-01Read Markdown21.57-47.3% to today ✓Accumulation gives way to Markdown with volume flow in agreement
2026-08-27Read Accumulation21.57-47.3% to today Distribution gives way to Accumulation after a 5% slide in 3 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Planet Labs PBC holds its Markdown at $11.37. The statistical read favours the sellers, held for 57 days.
As held on the ledger · 2026-11-05
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 57 days
Price at the screen
$11.37
Valuation
N/A trailing · -10,808.00 forward price to earnings
Values screen
FAIL· score 30.0
Beta
2.27
The Workings
Five Screens, Shown in Full
Does not pass. Excluded industry: Aerospace & Defense
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Excluded industry: Aerospace & Defense
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Planet Labs PBC does not clear the screen at the business-activity stage. It operates in aerospace and defense, so the financial ratios are not the deciding factor here.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PL's ethical verdict changes
Today PL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 2.21x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Satellites promise daily earth views but ethics block
Picture a fleet of small satellites beaming fresh photos of every corner of the globe each day. Planet Labs built that network to sell the data to governments and firms. We pass because the business fails our ethical screen on aerospace and defence work.
Revenue is growing fast yet the company still loses more than a dollar for every dollar earned, with returns on equity deeply negative. The shares trade well above our fair value and carry a forward multiple that leaves no margin for error. The narrow moat offers little protection against those realities.
Analyst price targets look optimistic on paper alone. The industry exclusion remains firm regardless of growth or sentiment. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PL trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markdown$13.47-0.7%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. Insiders have been net sellers over the past quarter.
2026-10-25Markdown$13.56+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. Insiders have been net sellers over the past quarter.
2026-10-18Markdown · changed$13.56-17.2%Entry 15
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 17.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. Insiders have been net sellers over the past quarter.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. Insiders have been net sellers over the past quarter.
2026-10-02Markdown$16.38-24.1%Entry 13
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 24.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. Insiders have been net sellers over the past quarter.
2026-09-03Markdown$21.57+0.0%Entry 12
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-02Markdown$21.57+0.0%Entry 11
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markdown · changed$21.57+0.0%Entry 10
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Accumulation$21.57+0.0%Entry 9
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Accumulation$21.57+0.0%Entry 8
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
